Fraction metabolized by cytochrome P450 enzymes: A comprehensive evaluation of the translatability of an in vitro HepatoPac assayDrug Metabolism and DispositionIF42026-01-150PRE
Combined Fainting and Psychogenic Non-epileptic Seizures as Significant Therapy Hurdles in Blood-Injury-Injection Phobia: A Mini-Review and Case ReportFRONTIERS IN PSYCHIATRYIF3.22022-07-120OAAI
In Vitro to In Vivo Extrapolation of Metabolic Clearance for UGT Substrates Using Short-Term Suspension and Long-Term Co-cultured Human Hepatocytes (vol 22, 131, 2020)AAPS JOURNALIF3.72020-11-061OAAI
In VitrotoIn VivoExtrapolation of Metabolic Clearance for UGT Substrates Using Short-Term Suspension and Long-Term Co-cultured Human HepatocytesAAPS JOURNALIF3.72020-10-1322PREAI
Fundamental aspects of DMPK optimization of targeted protein degradersDRUG DISCOVERY TODAYIF7.52020-06-01101PREAI
A novel mechanism-based pharmacokinetic-pharmacodynamic (PKPD) model describing ceftazidime/avibactam efficacy against β-lactamase-producing Gram-negative bacteriaJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62019-10-3120PREAI
Simultaneous Assessment of Clearance, Metabolism, Induction, and Drug-Drug Interaction Potential Using a Long-Term In Vitro Liver Model for a Novel Hepatitis B Virus InhibitorJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82018-05-0114OAAI
Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects ModelingAAPS JOURNALIF3.72017-01-0388OAAI
Targeted γ-Secretase Inhibition To Control the Notch Pathway in Renal DiseasesJOURNAL OF MEDICINAL CHEMISTRYIF6.82015-10-1216PREAI
Improved oral bioavailability of cyclosporin A in male Wistar rats -: Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspensionINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22002-10-0137PREAI
Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450INTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22000-12-0193PREAI